Clinical Trial

Prior CABG Patients Evaluated for Saphenous VeIn grAft DysfUnction and Progression of Coronary arTery Disease

Study acronym: VIADUCT
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 2, 2023 (before its estimated July 23, 2024 completion). Its status may not reflect the trial's current state.
Summary
This is a multi-center, observational cohort study including patients with prior coronary artery bypass grafting (CABG) and ≥1 saphenous vein grafts (SVG) presenting with recurrent ischemic symptoms. Objective: to investigate the clinical outcomes in patients with prior CABG evaluated for bypass graft failure and progression of native coronary artery disease (CAD). Follow-up will be collected through national registry databases, electronic medical patient records and standardized telephonic assessment at 3 and 5 years follow-up.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2021-02-22; most recent amendment 2023-05-30.
Trial Details
NCT Number NCT04772768
Lead Sponsor Amsterdam UMC, location VUmc
Conditions Recurrent Angina After Coronary Artery Bypass Graft, Graft Failure, Coronary Artery Disease Progression
Enrollment 500 participants
Start Date 2019-08-23
Primary Completion 2024-07-23 (estimated)
Study Completion 2029-07-23 (estimated)
Updated on ClinicalTrials.gov 2023-06-02